Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 95.4B | 124.3B | 94.9B | 85.8B |
| Cost of revenue | 50.5B | 66.0B | 51.1B | 46.1B |
| Gross profit | 44.9B | 58.3B | 43.9B | 39.7B |
| Operating expense | ||||
| Research & development | 8.6B | 8.3B | 7.8B | 8.0B |
| Selling general and admin | 6.7B | 7.2B | 6.5B | 6.3B |
| Other operating expenses | — | — | — | — |
| Operating income | 29.6B | 42.8B | 29.6B | 25.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | -279M | -248M | 19M | 142M |
| Pretax income | 29.3B | 42.6B | 29.6B | 25.5B |
| Tax provision | 4.5B | 6.3B | 14.9B | 4.0B |
| Net income | 24.8B | 36.3B | 14.7B | 21.4B |
| Basic EPS | 1.7 | 2.4 | 1.0 | 1.4 |
| Diluted EPS | 1.7 | 2.4 | 1.0 | 1.4 |
| Basic average shares | 15.0B | 15.1B | 15.2B | 15.3B |
| Diluted average shares | 15.1B | 15.2B | 15.2B | 15.3B |
| EBITDA | 32.3B | 45.9B | 32.5B | 28.2B |
| Net income from continuing op. | 24.8B | 36.3B | 14.7B | 21.4B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |